Search research articles
Contact Us
Filters
Showing results (131-140 of 146) with videos related to
Page
of 15
Sort By:
Journal of Hepatology
|
November 17, 2021
Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis
Xinxing Tantai, Yi Liu, Yee Hui Yeo, et al.
The Lancet. Gastroenterology & Hepatology
|
March 24, 2019
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis
Jie Li, Biyao Zou, Yee Hui Yeo, et al.
Journal of Gastroenterology and Hepatology
|
August 26, 2020
High hepatitis C virus cure rates with approved interferon-free direct-acting antivirals among diverse mainland Chinese patients including genotypes 3a and 3b
Fanpu Ji, Jie Li, Li Liu, et al.
Journal of Hepatology
|
May 17, 2019
Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis
Fanpu Ji, Yee Hui Yeo, Mike Tzuhen Wei, et al.
Therapeutic Advances in Gastroenterology
|
May 23, 2022
Practice guidance for the use of terlipressin for liver cirrhosis-related complications
Xingshun Qi, Zhaohui Bai, Qiang Zhu, et al.
Alimentary Pharmacology & Therapeutics
|
March 31, 2026
Camrelizumab and Apatinib With or Without Transarterial Chemoembolisation as First-Line Treatment for Advanced Hepatocellular Carcinoma (CHANCE2311)
Rong Ding, Jin-Feng Bai, Zhi-Cheng Jin, et al.
Eclinicalmedicine
|
February 18, 2026
Transarterial chemoembolization (TACE) combined with immunotherapy and anti-angiogenic agents in intermediate-stage hepatocellular carcinoma (CHANCE2202): a target trial emulation study
Jian-Jian Chen, Zhi-Cheng Jin, Jia-Wei Zhou, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
November 27, 2024
Longitudinal Body Composition Identifies Hepatocellular Carcinoma With Cachexia Following Combined Immunotherapy and Target Therapy (CHANCE2213)
Zhi-Cheng Jin, Jia-Wei Zhou, Jian-Jian Chen, et al.
Medcomm
|
November 27, 2025
Variations in Estimated Glomerular Filtration Rate Across Countries in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and Their Association With Liver Fibrosis: A Multicenter Study
Jing Zhao, Ferenc E Mózes, Xin-Yu Xu, et al.
Hepatology (Baltimore, Md.)
|
December 7, 2024
Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapy
Bernhard Scheiner, Beodeul Kang, Lorenz Balcar, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 146) with videos related to
Sort By:
Page
of 15
Journal of Hepatology
|
November 17, 2021
Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis
Xinxing Tantai, Yi Liu, Yee Hui Yeo, et al.
The Lancet. Gastroenterology & Hepatology
|
March 24, 2019
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis
Jie Li, Biyao Zou, Yee Hui Yeo, et al.
Journal of Gastroenterology and Hepatology
|
August 26, 2020
High hepatitis C virus cure rates with approved interferon-free direct-acting antivirals among diverse mainland Chinese patients including genotypes 3a and 3b
Fanpu Ji, Jie Li, Li Liu, et al.
Journal of Hepatology
|
May 17, 2019
Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis
Fanpu Ji, Yee Hui Yeo, Mike Tzuhen Wei, et al.
Therapeutic Advances in Gastroenterology
|
May 23, 2022
Practice guidance for the use of terlipressin for liver cirrhosis-related complications
Xingshun Qi, Zhaohui Bai, Qiang Zhu, et al.
Alimentary Pharmacology & Therapeutics
|
March 31, 2026
Camrelizumab and Apatinib With or Without Transarterial Chemoembolisation as First-Line Treatment for Advanced Hepatocellular Carcinoma (CHANCE2311)
Rong Ding, Jin-Feng Bai, Zhi-Cheng Jin, et al.
Eclinicalmedicine
|
February 18, 2026
Transarterial chemoembolization (TACE) combined with immunotherapy and anti-angiogenic agents in intermediate-stage hepatocellular carcinoma (CHANCE2202): a target trial emulation study
Jian-Jian Chen, Zhi-Cheng Jin, Jia-Wei Zhou, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
November 27, 2024
Longitudinal Body Composition Identifies Hepatocellular Carcinoma With Cachexia Following Combined Immunotherapy and Target Therapy (CHANCE2213)
Zhi-Cheng Jin, Jia-Wei Zhou, Jian-Jian Chen, et al.
Medcomm
|
November 27, 2025
Variations in Estimated Glomerular Filtration Rate Across Countries in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and Their Association With Liver Fibrosis: A Multicenter Study
Jing Zhao, Ferenc E Mózes, Xin-Yu Xu, et al.
Hepatology (Baltimore, Md.)
|
December 7, 2024
Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapy
Bernhard Scheiner, Beodeul Kang, Lorenz Balcar, et al.
Page
of 15